Prostaglandin E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord

Neuronal degeneration, distinguished morphologically and biochemically from necrosis, was induced in the dorsal horn of the lumbar spinal cord by chronic constriction of the sciatic nerve in rats. Neuronal apoptosis in the territory of the spinal cord which receives afferent excitatory inputs from the sciatic nerve was confirmed by TUNEL-staining and electrophoresis of genomic DNA. The morphological changes including the appearance of dark neurones, as identified by toluidine-blue staining, were almost completely blocked by 10 microg/kg of the prostaglandin E (EP) receptor agonist lipo-PGE1, incorporating PGE1 in lipid microspheres for chemical stability and targeted delivery, but not by 10 microg/kg of carbacyclin a prostacyclin (IP) receptor agonist. Lipo-PGE1 also blocked the "ladder type" fragmentation of genomic DNA extracted from tissue in the affected area of the spinal cord. Since the regional blood flow in the subfield of the spinal cord was neither influenced by the chronic injury nor by application of the vasodilative prostaglandin, the effect of lipo-PGE1 must have been achieved via another mechanism. These results demonstrate that the neuronal apoptosis in spinal cord induced by sciatic constriction injury is more effectively inhibited by the EP receptor agonist PGE1 than by the IP receptor agonist carbacyclin.

[1]  M. Vasko,et al.  Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  Y. Hirata,et al.  Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers. , 1993, Prostaglandins.

[3]  C. Thompson,et al.  bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. , 1994, Development.

[4]  R. Shigemoto,et al.  Distribution of the messenger rna for the prostaglandin e receptor subtype ep3 in the mouse nervous system , 1994, Neuroscience.

[5]  S. Narumiya,et al.  Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype. , 1994, Biochemical and biophysical research communications.

[6]  D. Rigal,et al.  Effects of PGE2 upon differentiation and programmed cell death of suspension cultured CD4-CD8- thymocytes. , 1994, International journal of immunopharmacology.

[7]  D. Sarkar,et al.  Cyclic AMP and ethanol interact to control apoptosis and differentiation in hypothalamic beta-endorphin neurons. , 1994, The Journal of biological chemistry.

[8]  M. Vasko,et al.  Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  Y. Hao,et al.  Altered cAMP levels in retinas from transgenic mice expressing a rhodopsin mutant. , 1995, Biochemical and biophysical research communications.

[10]  H. Hashimoto,et al.  A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders. , 1987, The Journal of rheumatology.

[11]  A. Gilman.  G proteins and dual control of adenylate cyclase , 1984, Cell.

[12]  C. Maggi,et al.  Arachidonic acid and bradykinin share a common pathway to release neuropeptide from capsaicin-sensitive sensory nerve fibers of the guinea pig heart. , 1991, The Journal of pharmacology and experimental therapeutics.

[13]  M. Schramm,et al.  Message transmission: receptor controlled adenylate cyclase system. , 1984, Science.

[14]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[15]  S. Narumiya,et al.  Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity , 1994, Brain Research.

[16]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[17]  Carol A. Barnes,et al.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids , 1993, Neuron.

[18]  R. Lockshin,et al.  Cell death in biology and pathology , 1981 .

[19]  T. Yoshimoto,et al.  Glutamate triggers internucleosomal DNA cleavage in neuronal cells. , 1991, Biochemical and biophysical research communications.

[20]  K. Hoshi,et al.  Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery. , 1993, Journal of drug targeting.

[21]  E. Goetzl,et al.  Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts. , 1995, Journal of immunology.

[22]  A. Wyllie,et al.  Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.

[23]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[24]  J E Swett,et al.  The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord , 1985, The Journal of comparative neurology.

[25]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[26]  T. Nagasaka,et al.  Effects of a single drip infusion of lipo-prostaglandin E1 on vibratory threshold in patients with diabetic neuropathy. , 1995, Prostaglandins.

[27]  M. Krönke,et al.  The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin‐1 signal transduction , 1994, Journal of leukocyte biology.

[28]  Gwyn T. Williams,et al.  Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis , 1991, Nature.

[29]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[30]  Gary J. Bennett,et al.  Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine , 1990, Pain.

[31]  B. Trump,et al.  Cell death and the disease process. The role of calcium , 1981 .

[32]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[33]  H. Steller,et al.  Genetic control of programmed cell death in Drosophila. , 1994, Science.

[34]  B. Jastorff,et al.  Induction of apoptosis in thymocytes: new evidence for an interaction of PKC and PKA pathways. , 1995, Biological chemistry Hoppe-Seyler.